Clinical Trial Update: Pemetrexed Disodium in Treating Patients With Recurrent Cancer of the Cervix [Phase 2]

View source ↗

Summary

Phase 2 trial of pemetrexed disodium for recurrent cervical cancer has completed; the update notes the study status but does not provide results in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Pemetrexed disodium (Pemetrexed disodium)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Cervical Cancer | Phase 2 | Status: COMPLETED